Tandoori Roasted Peanut; Net. Wt 4.94 oz Laminated Pouches; packed in cases consisting of 24 pouches
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0816-2023.
Undeclared Milk
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0816-2023.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Jabsons Foods Private Limited (formerly Known As Jabsons Cottonseed Ind.pvt.ltd.) or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0816-2023.
JABSONS FOODS PRIVATE LIMITED (Formerly Known as Jabsons Cottonseed Ind.Pvt.Ltd.)
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Jabsons Foods Private Limited (formerly Known As Jabsons Cottonseed Ind.pvt.ltd.) Recall FAQ
Jabsons Foods Private Limited (formerly Known As Jabsons Cottonseed Ind.pvt.ltd.) is the subject of a food safety report: Tandoori Roasted Peanut; Net. Wt 4.94 oz Laminated Pouches; packed in cases consisting of 24 pouches. The notice was published on March 19, 2023 by the U.S. Food and Drug Administration (FDA). Approximately 1,034 units are potentially affected.